Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,968 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression.
Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T. Kobayashi K, et al. Among authors: matsumoto s. Cancer Res. 2000 Jul 15;60(14):3978-84. Cancer Res. 2000. PMID: 10919677
Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K, Yamaguchi A, Miura K, Kato T, Baba S, Matsumoto S, Ishii M, Takagi H. Ito K, et al. Among authors: matsumoto s. J Surg Oncol. 1996 Oct;63(2):107-11. doi: 10.1002/(SICI)1096-9098(199610)63:2<107::AID-JSO7>3.0.CO;2-I. J Surg Oncol. 1996. PMID: 8888803 Clinical Trial.
Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
Tsujitani S, Konishi I, Suzuki K, Oka S, Gomyo Y, Matsumoto S, Hirooka Y, Kaibara N. Tsujitani S, et al. Among authors: matsumoto s. J Exp Clin Cancer Res. 2000 Jun;19(2):189-95. J Exp Clin Cancer Res. 2000. PMID: 10965817
Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.
Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Matsumoto S, et al. Br J Cancer. 2002 Jan 21;86(2):161-7. doi: 10.1038/sj.bjc.6600048. Br J Cancer. 2002. PMID: 11870500 Free PMC article. Clinical Trial.
Updated results from GEST study: a randomized, three-arm phase III study for advanced pancreatic cancer.
Okusaka T, Miyakawa H, Fujii H, Nakamori S, Satoh T, Hamamoto Y, Ito T, Maguchi H, Matsumoto S, Ueno H, Ioka T, Boku N, Egawa S, Hatori T, Furuse J, Mizumoto K, Ohkawa S, Yamaguchi T, Yamao K, Funakoshi A, Chen JS, Cheng AL, Sato A, Ohashi Y, Tanaka M; GEST group. Okusaka T, et al. Among authors: matsumoto s. J Cancer Res Clin Oncol. 2017 Jun;143(6):1053-1059. doi: 10.1007/s00432-017-2349-y. Epub 2017 Feb 16. J Cancer Res Clin Oncol. 2017. PMID: 28210843 Free PMC article. Clinical Trial.
Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T. Shibuya H, et al. Among authors: matsumoto s. Cancer Chemother Pharmacol. 2018 Oct;82(4):661-668. doi: 10.1007/s00280-018-3656-y. Epub 2018 Jul 27. Cancer Chemother Pharmacol. 2018. PMID: 30054710
Effect of oral adjuvant therapy with Carmofur (HCFU) for distant metastasis of colorectal cancer.
Ito K, Yamaguchi A, Miura K, Kato T, Baba S, Matsumoto S, Ishii M, Takagi H. Ito K, et al. Among authors: matsumoto s. Int J Clin Oncol. 2000 Feb;5(1):29-35. doi: 10.1007/s101470050006. Int J Clin Oncol. 2000. PMID: 20563694
Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma.
Tanaka T, Sho M, Takayama T, Wakatsuki K, Matsumoto S, Migita K, Ito M, Hamada K, Nakajima Y. Tanaka T, et al. Among authors: matsumoto s. Br J Cancer. 2014 Feb 18;110(4):1027-33. doi: 10.1038/bjc.2013.784. Epub 2013 Dec 19. Br J Cancer. 2014. PMID: 24357795 Free PMC article.
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).
Sakai D, Taniguchi H, Sugimoto N, Tamura T, Nishina T, Hara H, Esaki T, Denda T, Sakamoto T, Okuda H, Satoh T, Tsushima T, Makiyama A, Tsuda T, Hosokawa A, Kuramochi H, Tokunaga S, Moriwaki T, Yasui H, Ishida H, Tsuji A, Otsu S, Shimokawa H, Baba E, Sato M, Matsumoto S, Ozaki Y, Shinozaki K, Tamagawa H, Goto M, Kadowaki S, Fujii H, Koh Y, Yamazaki K, Hironaka S, Kishimoto J, Boku N, Hyodo I, Muro K. Sakai D, et al. Among authors: matsumoto s. Eur J Cancer. 2020 Aug;135:11-21. doi: 10.1016/j.ejca.2020.04.014. Epub 2020 Jun 8. Eur J Cancer. 2020. PMID: 32526634
A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer.
Suzuki R, Hasegawa Y, Baba K, Saka H, Saito H, Taniguchi H, Yamamoto M, Matsumoto S, Kato K, Oishi T, Imaizumi K, Shimokata K. Suzuki R, et al. Among authors: matsumoto s. Br J Cancer. 2006 Jun 5;94(11):1599-603. doi: 10.1038/sj.bjc.6603159. Br J Cancer. 2006. PMID: 16670714 Free PMC article. Clinical Trial.
4,968 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback